CA-125, a commonly used tumor marker for epithelial ovarian cancer, is a glycoprotein found in normal tissues derived from coelomic epithelia. Increased serum levels of CA-125 have also been found in nongynecologic tumors and nonmalignant diseases involving the peritoneum. A few recent studies and sporadic case reports have reported increased CA-125 levels in patients with non-Hodgkin's lymphoma (NHL). In our study, we aimed to evaluate the serum levels of CA-125 in patients with NHL and determine its potential role to show disease activity in NHL. Serum levels of CA-125 were measured in 61 patients with NHL and were found to be correlated with clinical stage, site of involvement, and disease activity.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000421-199912000-00014DOI Listing

Publication Analysis

Top Keywords

serum levels
12
levels ca-125
12
tumor marker
8
non-hodgkin's lymphoma
8
patients nhl
8
disease activity
8
ca-125
6
epithelial tumor
4
marker ca-125
4
ca-125 non-hodgkin's
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!